Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Aug 23, 2021 10:28am
235 Views
Post# 33748064

RE:Fighting Fire with Fire: Virus Therapy as a Cancer Tr

RE:Fighting Fire with Fire: Virus Therapy as a Cancer Tr

There are countless indicators outside of ONC showing the huge potential of Pelareorep.
once to market, with one application alone, well over $5 billion/ year in sales ( RBC analyst study).
What does $5 billion/ yr in sales translate to in company worth?

Depends on many variables.  partnership arrangement, profit margins, distribution costs etc etc.
one thing for 100% certain...worth many multiples of what the SP is trading at now.
Pela notably is not near being approved for market yet.
They are working on multiple fronts.
with Pfizer, Roche, BMS, Incyte, Merck.
My interest recently is the CaR-t , study. 

THAT , could prove to be the spring board to launch, the SP , credibility & eventual phase 3 trial partner.
A while back I predicted May-Aug window, for an announcement of a CAR- T , partnership.
One more week. I'll either be right or wrong with my " prediction".
regardless"...........
looking at the long game?
ONC has operating cash to Q1 2023.
about 4 major milestones, published to be reporting by end of this year.
Assuming things run late. Takes us to Q1 of next yr. aka 4-7 months , with known opportunities.
Share price?
On even a smidgen of good news, much higher & fast.
The analysts following Onc have openly asked for details on the phase 3 deal & progress.
Essentially do or die. To be decided like I said, between now & March.
Buy? sell? Hold ? Short?
 The highest risk right now is shorting. The upside potential is 10x to 20x today's price.
Regardless of short holdings, a price rise will create a short squeeze.
Want to know what that looks like?
look at Dec 2019. Was moving upwards 20%-40% per day.
Selling ?
depends when you bought, timelines & motivation.
Buying ?
Read the company web investor presentation. Make an informed decision.
Do not go by any drivel on chat sites, including myself.
I have a reasonable amount of ONC shares & quite happy to hold, waiting for pending outcomes.
A decision I made many months ago. I'm in until they either get to market or announce failure.
All indications lean towards success.
BTW the trading SP, has little to do with future success.
I like to use Apple as a great example. 
could have bought Apple shares for $1. Back in the dot- com days.
chat rooms were full of doom & gloom predictions.
Afterall, it's onky trading at $1. Must be junk.
And the rest is history.
 


 

<< Previous
Bullboard Posts
Next >>